Profile
Wilbur H.
Gantz is the founder of PathoCapital LLC, which was founded in 2009.
He holds the title of President & Chief Executive Officer at PathoCapital LLC.
Currently, Mr. Gantz holds the position of Chairman at The Field Museum of Natural History, Director at Brain Research Foundation, and Director at Reliefband Technologies LLC.
In the past, Mr. Gantz served as Chairman & Chief Executive Officer at PathoGenesis Corp.
He was also the Executive Chairman at Naurex, Inc. from 2013 to 2015, and at OVATION Pharmaceuticals, Inc. from 2002 to 2010.
Additionally, he served as a Director at Gillette Co., Lead Independent Director at W.W.
Grainger, Inc. from 2011 to 2013, and as a Director at Gambro AB. Mr. Gantz was an Independent Director at Aevi Genomic Medicine, Inc. from 2013 to 2018, and a Director at Aptinyx, Inc. from 2015 to 2020.
He also served as a Director at Harmony Biosciences Holdings, Inc. and Harmony Biosciences LLC.
From 1966 to 1992, Mr. Gantz held the position of President at Baxter International, Inc. He was also a Partner at Adams Street Partners LLC in 2013.
Mr. Gantz completed his undergraduate degree at Princeton University in 1959.
He also obtained an MBA from Harvard Business School in 1964.
Bill Gantz active positions
| Companies | Position | Start |
|---|---|---|
PathoCapital LLC
PathoCapital LLC Financial ConglomeratesFinance Operates as an investment company | Chief Executive Officer | 2009-02-28 |
The Field Museum of Natural History
The Field Museum of Natural History Other Consumer ServicesConsumer Services Operates as a public museum | Chairman | - |
Reliefband Technologies LLC
Reliefband Technologies LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells wearable band through online store which controls nausea and vomiting | Director/Board Member | - |
Brain Research Foundation
Brain Research Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research of neuroscience for novel treatments | Director/Board Member | - |
Former positions of Bill Gantz
| Companies | Position | End |
|---|---|---|
| APTINYX | Chairman | 2020-05-19 |
| AEVI GENOMIC MEDICINE, INC. | Director/Board Member | 2018-06-13 |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Chairman | 2014-12-31 |
Gillette Co.
Gillette Co. Home FurnishingsConsumer Durables Manufactures razors, blades, personal care products and shaving kits | Director/Board Member | 2006-02-28 |
| BAXTER INTERNATIONAL INC. | President | - |
Training of Bill Gantz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Gillette Co.
Gillette Co. Home FurnishingsConsumer Durables Manufactures razors, blades, personal care products and shaving kits | Consumer Durables |
W.W. Grainger, Inc.
W.W. Grainger, Inc. Wholesale DistributorsDistribution Services Distributes maintenance, repair and operating (MRO) products | Distribution Services |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
Adams Street Partners LLC
Adams Street Partners LLC Investment ManagersFinance Adams Street Partners invests in companies globally with revenues of at least USD 5 million and enterprise value of USD 150 - 750 million. The firm targets companies operating in the fields of category-leading software, mobile, healthcare, security, and financial technology sectors. The firm provides financing for secondary, growth equity, credit, and co-investment strategies with an investment size of USD 20 - 50 million. The firm acts as co-investor and takes a board seat. It also makes follow-on investments. | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
The Field Museum of Natural History
The Field Museum of Natural History Other Consumer ServicesConsumer Services Operates as a public museum | Consumer Services |
PathoCapital LLC
PathoCapital LLC Financial ConglomeratesFinance Operates as an investment company | Finance |
Brain Research Foundation
Brain Research Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research of neuroscience for novel treatments | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reliefband Technologies LLC
Reliefband Technologies LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells wearable band through online store which controls nausea and vomiting | Electronic Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
- Stock Market
- Insiders
- Bill Gantz
















